APEX Research was founded 1994 as one of the first European CRO´s specialized in pharmacokinetic studies with patients. APEX stands for "A"pplied "P"harmacology and "EX"perimental Pharmacotherapy. Our vision is to define applied pharmacology as a tool to accelerate drug development. Our concept is to include the patient into the drug development process safely, early, and effectively. Our area of expertise is the clinical performance of phase I and phase IIa studies in our own clinical unit. Our patients are patients with impaired hepatic or renal function, diabetes patients, asthma patients, hypertensive patients and other patients with chronic stabile diseases. Our cooperation partners: GP's, clinicians, CRO's, specialized labs. Our clients are leading international pharmaceutical companies.